| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 1.22e-09 | 37 | 111 | 7 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 1.48e-09 | 38 | 111 | 7 | GO:0070001 | |
| GeneOntologyBiologicalProcess | nuclear-transcribed mRNA poly(A) tail shortening | 2.88e-05 | 33 | 111 | 4 | GO:0000289 | |
| GeneOntologyBiologicalProcess | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 5.29e-05 | 14 | 111 | 3 | GO:0060213 | |
| GeneOntologyBiologicalProcess | regulation of nuclear-transcribed mRNA poly(A) tail shortening | 8.07e-05 | 16 | 111 | 3 | GO:0060211 | |
| GeneOntologyBiologicalProcess | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 8.07e-05 | 16 | 111 | 3 | GO:1900153 | |
| GeneOntologyBiologicalProcess | cell-cell fusion | 9.60e-05 | 85 | 111 | 5 | GO:0140253 | |
| GeneOntologyBiologicalProcess | syncytium formation by plasma membrane fusion | 9.60e-05 | 85 | 111 | 5 | GO:0000768 | |
| GeneOntologyBiologicalProcess | syncytium formation | 1.19e-04 | 89 | 111 | 5 | GO:0006949 | |
| Domain | PolyA | 1.66e-06 | 5 | 104 | 3 | SM00517 | |
| Domain | - | 1.66e-06 | 5 | 104 | 3 | 1.10.1900.10 | |
| Domain | PABP | 1.66e-06 | 5 | 104 | 3 | PF00658 | |
| Domain | PABC | 1.66e-06 | 5 | 104 | 3 | PS51309 | |
| Domain | PABP_1234 | 1.66e-06 | 5 | 104 | 3 | IPR006515 | |
| Domain | PABP_HYD | 1.66e-06 | 5 | 104 | 3 | IPR002004 | |
| Domain | - | 1.83e-04 | 4 | 104 | 2 | 1.10.10.440 | |
| Domain | RRM_dom_euk | 2.74e-04 | 23 | 104 | 3 | IPR003954 | |
| Domain | RRM_1 | 2.74e-04 | 23 | 104 | 3 | SM00361 | |
| Domain | Anaphylatoxin_comp_syst | 3.04e-04 | 5 | 104 | 2 | IPR018081 | |
| Domain | Anaphylatoxn_comp_syst_dom | 3.04e-04 | 5 | 104 | 2 | IPR001840 | |
| Domain | FF | 4.54e-04 | 6 | 104 | 2 | PF01846 | |
| Domain | FF | 4.54e-04 | 6 | 104 | 2 | SM00441 | |
| Domain | FF_domain | 4.54e-04 | 6 | 104 | 2 | IPR002713 | |
| Domain | FF | 4.54e-04 | 6 | 104 | 2 | PS51676 | |
| Domain | ANATO | 6.33e-04 | 7 | 104 | 2 | SM00104 | |
| Domain | ANATO | 6.33e-04 | 7 | 104 | 2 | PF01821 | |
| Domain | ANAPHYLATOXIN_2 | 6.33e-04 | 7 | 104 | 2 | PS01178 | |
| Domain | ANAPHYLATOXIN_1 | 6.33e-04 | 7 | 104 | 2 | PS01177 | |
| Domain | Anaphylatoxin/fibulin | 6.33e-04 | 7 | 104 | 2 | IPR000020 | |
| Domain | Thiol-ester_cl | 8.41e-04 | 8 | 104 | 2 | PF10569 | |
| Domain | MacrogloblnA2_thiol-ester-bond | 8.41e-04 | 8 | 104 | 2 | IPR019565 | |
| Domain | MacrogloblnA2_CS | 8.41e-04 | 8 | 104 | 2 | IPR019742 | |
| Domain | RRM_1 | 1.09e-03 | 208 | 104 | 6 | PF00076 | |
| Domain | A2M_N | 1.34e-03 | 10 | 104 | 2 | PF01835 | |
| Domain | A2M_N | 1.34e-03 | 10 | 104 | 2 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 1.34e-03 | 10 | 104 | 2 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 1.34e-03 | 10 | 104 | 2 | PS00477 | |
| Domain | A2M | 1.34e-03 | 10 | 104 | 2 | PF00207 | |
| Domain | A2M_N_2 | 1.34e-03 | 10 | 104 | 2 | IPR011625 | |
| Domain | A2M_comp | 1.34e-03 | 10 | 104 | 2 | IPR011626 | |
| Domain | A2M_N_2 | 1.34e-03 | 10 | 104 | 2 | PF07703 | |
| Domain | A2M_recep | 1.34e-03 | 10 | 104 | 2 | PF07677 | |
| Domain | A2M_comp | 1.34e-03 | 10 | 104 | 2 | PF07678 | |
| Domain | Macroglobln_a2 | 1.34e-03 | 10 | 104 | 2 | IPR001599 | |
| Domain | RRM | 1.35e-03 | 217 | 104 | 6 | SM00360 | |
| Domain | RRM_dom | 1.70e-03 | 227 | 104 | 6 | IPR000504 | |
| Domain | RRM | 1.82e-03 | 230 | 104 | 6 | PS50102 | |
| Domain | WW | 2.28e-03 | 47 | 104 | 3 | PF00397 | |
| Domain | WHTH_DNA-bd_dom | 2.35e-03 | 242 | 104 | 6 | IPR011991 | |
| Domain | WW | 2.42e-03 | 48 | 104 | 3 | SM00456 | |
| Domain | - | 2.44e-03 | 244 | 104 | 6 | 3.30.70.330 | |
| Domain | Ldl_recept_b | 2.68e-03 | 14 | 104 | 2 | PF00058 | |
| Domain | LDLRB | 2.68e-03 | 14 | 104 | 2 | PS51120 | |
| Domain | WW_DOMAIN_2 | 2.88e-03 | 51 | 104 | 3 | PS50020 | |
| Domain | WW_DOMAIN_1 | 2.88e-03 | 51 | 104 | 3 | PS01159 | |
| Domain | WW_dom | 3.04e-03 | 52 | 104 | 3 | IPR001202 | |
| Domain | LY | 3.08e-03 | 15 | 104 | 2 | SM00135 | |
| Domain | LDLR_classB_rpt | 3.08e-03 | 15 | 104 | 2 | IPR000033 | |
| Domain | Nucleotide-bd_a/b_plait | 3.22e-03 | 258 | 104 | 6 | IPR012677 | |
| Domain | C345C | 3.95e-03 | 17 | 104 | 2 | SM00643 | |
| Domain | Terpenoid_cyclase/PrenylTrfase | 4.43e-03 | 18 | 104 | 2 | IPR008930 | |
| Domain | NTR | 4.94e-03 | 19 | 104 | 2 | PF01759 | |
| Domain | Netrin_module_non-TIMP | 4.94e-03 | 19 | 104 | 2 | IPR018933 | |
| Pubmed | 2.58e-10 | 12 | 113 | 5 | 14557543 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | RALGAPA1 SYNRG CCDC8 SHROOM3 HIVEP1 ABL1 SORBS1 KIAA1191 PABPC1 FSIP2 PLEKHG1 TCERG1 RAB3GAP2 NAV2 NAV1 MACF1 PEAK1 | 2.89e-09 | 861 | 113 | 17 | 36931259 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SYNRG SHROOM3 FOXK2 ABL1 NLRX1 KAT6A ICE1 TNRC6C GTF2IRD1 BAHD1 PLEKHG1 SURF6 SBF2 NAV2 NAV1 LRP4 KCNQ2 WDFY3 ESPL1 | 2.98e-09 | 1105 | 113 | 19 | 35748872 |
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 2.57e-08 | 94 | 113 | 7 | 21542922 | |
| Pubmed | 3.34e-08 | 3 | 113 | 3 | 21940797 | ||
| Pubmed | Mapping of 12 markers in the proximal region of mouse chromosome 17 using recombinant t haplotypes. | 1.40e-07 | 15 | 113 | 4 | 7749235 | |
| Pubmed | 1.40e-07 | 15 | 113 | 4 | 2885372 | ||
| Pubmed | RALGAPA1 DDX17 CALD1 PABPC4 SORBS1 PABPC1 PITPNM1 SLC44A1 SF3B1 PABPC3 NAV1 PPP1R18 KCNQ2 MACF1 C4A C4B EIF3A PEAK1 AGAP2 | 1.77e-07 | 1431 | 113 | 19 | 37142655 | |
| Pubmed | 3.12e-07 | 18 | 113 | 4 | 18664271 | ||
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 3.32e-07 | 5 | 113 | 3 | 12629516 | |
| Pubmed | HIV- 1 protease inhibits Cap- and poly(A)-dependent translation upon eIF4GI and PABP cleavage. | 3.32e-07 | 5 | 113 | 3 | 19956697 | |
| Pubmed | 3.32e-07 | 5 | 113 | 3 | 26492470 | ||
| Pubmed | 3.32e-07 | 5 | 113 | 3 | 33744966 | ||
| Pubmed | Human MHC region harbors both susceptibility and protective haplotypes for coronary artery disease. | 6.63e-07 | 6 | 113 | 3 | 17212707 | |
| Pubmed | 6.63e-07 | 6 | 113 | 3 | 15063128 | ||
| Pubmed | 6.63e-07 | 6 | 113 | 3 | 10358005 | ||
| Pubmed | ELOA2 DDX17 CALD1 U2SURP PABPC4 JSRP1 PABPC1 ADAMTS12 SF3B1 GTF3C1 ZNF608 PABPC3 ARHGAP12 ANKRD30A NAV2 MACF1 EIF3A AGAP2 | 9.46e-07 | 1442 | 113 | 18 | 35575683 | |
| Pubmed | Linkage map of mouse chromosome 17: localization of 27 new DNA markers. | 1.07e-06 | 24 | 113 | 4 | 2574145 | |
| Pubmed | Chromosomal localization of three human poly(A)-binding protein genes and four related pseudogenes. | 1.16e-06 | 7 | 113 | 3 | 10543404 | |
| Pubmed | 1.44e-06 | 59 | 113 | 5 | 32382008 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | HIVEP1 DDX17 CALD1 U2SURP PABPC4 ICE1 BCOR PABPC1 SF3B1 TCERG1 PABPC3 SURF6 RBM15B PDS5A | 2.75e-06 | 954 | 113 | 14 | 36373674 |
| Pubmed | 2.77e-06 | 9 | 113 | 3 | 1373139 | ||
| Pubmed | 2.77e-06 | 9 | 113 | 3 | 24396066 | ||
| Pubmed | RALGAPA1 DDX17 CALD1 PABPC4 PABPC1 C1orf198 TCERG1 RAB3GAP2 ARHGAP12 MACF1 PDS5A PEAK1 | 3.50e-06 | 708 | 113 | 12 | 39231216 | |
| Pubmed | 3.94e-06 | 10 | 113 | 3 | 16798735 | ||
| Pubmed | 3.94e-06 | 10 | 113 | 3 | 19167759 | ||
| Pubmed | 3.94e-06 | 10 | 113 | 3 | 12970426 | ||
| Pubmed | 4.42e-06 | 130 | 113 | 6 | 12421765 | ||
| Pubmed | 4.45e-06 | 486 | 113 | 10 | 20936779 | ||
| Pubmed | 5.41e-06 | 11 | 113 | 3 | 21984184 | ||
| Pubmed | The UbL protein UBTD1 stably interacts with the UBE2D family of E2 ubiquitin conjugating enzymes. | 7.19e-06 | 12 | 113 | 3 | 24211586 | |
| Pubmed | 8.06e-06 | 220 | 113 | 7 | 24550385 | ||
| Pubmed | RALGAPA1 SHROOM3 SRRM4 ICE1 BCOR BAHD1 ZNF608 NAV2 LRP4 ESPL1 | 9.32e-06 | 529 | 113 | 10 | 14621295 | |
| Pubmed | Mapping of the L-methylmalonyl-CoA mutase gene to mouse chromosome 17. | 9.33e-06 | 13 | 113 | 3 | 1970332 | |
| Pubmed | The arginine methyltransferase CARM1 regulates the coupling of transcription and mRNA processing. | 9.33e-06 | 13 | 113 | 3 | 17218272 | |
| Pubmed | Inactivation of the microRNA-183/96/182 cluster results in syndromic retinal degeneration. | 9.33e-06 | 225 | 113 | 7 | 23341629 | |
| Pubmed | 9.53e-06 | 418 | 113 | 9 | 34709266 | ||
| Pubmed | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | RALGAPA1 GPRASP1 HIVEP1 BTBD10 UBXN6 RUSC1 KIAA1191 PABPC1 PITPNM1 C1orf198 EGF NECAB3 TEDC1 | 1.01e-05 | 925 | 113 | 13 | 28986522 |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 22737222 | ||
| Pubmed | Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection. | 1.05e-05 | 2 | 113 | 2 | 16565498 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 15998580 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 19020299 | ||
| Pubmed | Structural polymorphism of murine C4 and its linkage to H-2. | 1.05e-05 | 2 | 113 | 2 | 7373044 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 19062096 | ||
| Pubmed | The chemical structure of the C4d fragment of the human complement component C4. | 1.05e-05 | 2 | 113 | 2 | 3696167 | |
| Pubmed | Restriction fragment length polymorphism of the murine C4 and Slp genes: two C4 groups. | 1.05e-05 | 2 | 113 | 2 | 1357031 | |
| Pubmed | Structural comparison of human C4A3 and C4B1 after proteolytic activation by C1s. | 1.05e-05 | 2 | 113 | 2 | 16098595 | |
| Pubmed | Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice. | 1.05e-05 | 2 | 113 | 2 | 19933335 | |
| Pubmed | Structural basis for the C4d.1/C4d.2 serologic allotypes of murine complement component C4. | 1.05e-05 | 2 | 113 | 2 | 2459207 | |
| Pubmed | Antigen-induced B cell apoptosis is independent of complement C4. | 1.05e-05 | 2 | 113 | 2 | 17645767 | |
| Pubmed | Increased frequency of C4B*Q0 alleles in patients with Henoch-Schönlein purpura. | 1.05e-05 | 2 | 113 | 2 | 15787745 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 12207352 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 30026462 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 6559257 | ||
| Pubmed | Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients. | 1.05e-05 | 2 | 113 | 2 | 27758680 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 22387014 | ||
| Pubmed | Complement C4 Is Reduced in iPSC-Derived Astrocytes of Autism Spectrum Disorder Subjects. | 1.05e-05 | 2 | 113 | 2 | 34299197 | |
| Pubmed | Assessment of complement C4 gene copy number using the paralog ratio test. | 1.05e-05 | 2 | 113 | 2 | 20506482 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 12480675 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 26800705 | ||
| Pubmed | Complement C4 maintains peripheral B-cell tolerance in a myeloid cell dependent manner. | 1.05e-05 | 2 | 113 | 2 | 23749435 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 23918728 | ||
| Pubmed | Murine complement C4 is not required for experimental autoimmune encephalomyelitis. | 1.05e-05 | 2 | 113 | 2 | 15390104 | |
| Pubmed | Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein. | 1.05e-05 | 2 | 113 | 2 | 3037333 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 11726230 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 4216347 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 26971890 | ||
| Pubmed | Importance of the alpha 3-fragment of complement C4 for the binding with C4b-binding protein. | 1.05e-05 | 2 | 113 | 2 | 1699796 | |
| Pubmed | Structural insights into the human GW182-PABC interaction in microRNA-mediated deadenylation. | 1.05e-05 | 2 | 113 | 2 | 20098421 | |
| Pubmed | Sequence determination of the thiolester site of the fourth component of human complement. | 1.05e-05 | 2 | 113 | 2 | 6950384 | |
| Pubmed | Molecular cloning and characterization of complementary and genomic DNA clones for mouse C4 and Slp. | 1.05e-05 | 2 | 113 | 2 | 2997024 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 8660986 | ||
| Pubmed | Constitutive expression of Slp genes in mouse strain B10.WR directed by C4 regulatory sequences. | 1.05e-05 | 2 | 113 | 2 | 3624865 | |
| Pubmed | Tissue-specific RNA processing for the complement C4 gene transcript in the H-2k mouse strain. | 1.05e-05 | 2 | 113 | 2 | 8428773 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 9060628 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 21857912 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 24638111 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 6208559 | ||
| Pubmed | The role of the histocompatibility-2-linked Ss-Slp region in the control of mouse complement. | 1.05e-05 | 2 | 113 | 2 | 4514997 | |
| Pubmed | Transcriptional repression of C4 complement by hepatitis C virus proteins. | 1.05e-05 | 2 | 113 | 2 | 21345967 | |
| Pubmed | The inheritance of susceptibility to the Gross leukemia virus in mice. | 1.05e-05 | 2 | 113 | 2 | 5919331 | |
| Pubmed | An ancient provirus has imposed androgen regulation on the adjacent mouse sex-limited protein gene. | 1.05e-05 | 2 | 113 | 2 | 3167981 | |
| Pubmed | Evolutionary relationships within a subgroup of HERV-K-related human endogenous retroviruses. | 1.05e-05 | 2 | 113 | 2 | 9460924 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 7545960 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 30041577 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 2572548 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 2302180 | ||
| Pubmed | Complete cDNA sequence of the fourth component of murine complement. | 1.05e-05 | 2 | 113 | 2 | 3862104 | |
| Pubmed | The BS variant of C4 protects against age-related loss of white matter microstructural integrity. | 1.05e-05 | 2 | 113 | 2 | 34358307 | |
| Pubmed | Acute renal allograft rejection: diagnostic significance of focal peritubular capillary C4d. | 1.05e-05 | 2 | 113 | 2 | 18360261 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 22151770 | ||
| Pubmed | C4d-positive chronic rejection: a frequent entity with a poor outcome. | 1.05e-05 | 2 | 113 | 2 | 18091514 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 29080553 | ||
| Pubmed | Levels of free PABP are limited by newly polyadenylated mRNA in early Spisula embryogenesis. | 1.05e-05 | 2 | 113 | 2 | 10954604 | |
| Pubmed | Schizophrenia risk from complex variation of complement component 4. | 1.05e-05 | 2 | 113 | 2 | 26814963 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 6589636 | ||
| Pubmed | C4 Deficiency is a predisposing factor for Streptococcus pneumoniae-induced autoantibody production. | 1.05e-05 | 2 | 113 | 2 | 25339671 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 17728371 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 6149580 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 6149581 | ||
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 3.59e-04 | 9 | 58 | 2 | 1234 | |
| GeneFamily | RNA binding motif containing | 5.97e-04 | 213 | 58 | 5 | 725 | |
| GeneFamily | NLR family | 2.89e-03 | 25 | 58 | 2 | 666 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 4.30e-03 | 206 | 58 | 4 | 682 | |
| GeneFamily | Complement system|Sushi domain containing | 5.94e-03 | 36 | 58 | 2 | 492 | |
| GeneFamily | Glycosyltransferase family 6|Blood group antigens | 6.27e-03 | 37 | 58 | 2 | 454 | |
| GeneFamily | Potassium voltage-gated channels | 7.30e-03 | 40 | 58 | 2 | 274 | |
| GeneFamily | Ankyrin repeat domain containing | 7.55e-03 | 242 | 58 | 4 | 403 | |
| GeneFamily | Forkhead boxes | 8.39e-03 | 43 | 58 | 2 | 508 | |
| ToppCell | LA-06._Ventricular_Cardiomyocyte_II|LA / Chamber and Cluster_Paper | 2.76e-06 | 92 | 106 | 5 | fad2e02ae858e3a9bbe51ad1c689f7e31d11ce0e | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Bcl6-Excitatory_Neuron.Slc17a7.Bcl6-Ptgfr_(Postsubiculum)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.77e-06 | 98 | 106 | 5 | 9865a9de11dea6db0b75dd04fee523cd2da44766 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.75e-06 | 187 | 106 | 6 | d4b0afd9b92c47c8aa348bbd1af7eb54c3d478f2 | |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast-MatrixFB-A|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 6.49e-06 | 191 | 106 | 6 | e7c605b56934d1383237c1f946dbccef25d91368 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 6.89e-06 | 193 | 106 | 6 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | systemic_lupus_erythematosus-flare|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.97e-06 | 198 | 106 | 6 | 4c93ee921d56132d80832d8e94563f32ccf13bbc | |
| ToppCell | BLOOD--(0)_NK_cell-(0)_NK_cells_(CD56dim-like)|(0)_NK_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.53e-05 | 145 | 106 | 5 | 6dd81d53d006fcc206a10969374a11c372f92133 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.48e-05 | 155 | 106 | 5 | 77fdae85d36efb776db977eb424b32487ef222e4 | |
| ToppCell | Adult-Immune-mast_cell-D175|Adult / Lineage, Cell type, age group and donor | 3.93e-05 | 159 | 106 | 5 | 9f53fe2e0f25448d62a591c8e528e9a49b5400d5 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.17e-05 | 161 | 106 | 5 | a7e09cf2ca6cd70d40d08440fe9c5ab9befa1b79 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.17e-05 | 161 | 106 | 5 | 7d1bc73f4c82465b3f489d6737048b0cd54f22cf | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.17e-05 | 161 | 106 | 5 | 410eef62c83c704cbfc5a1b643c4db11bbdcd81f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Neural|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.17e-05 | 161 | 106 | 5 | 71022485da6754a2b57b4c3e758e3de4c95cc292 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Neural-neural_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.17e-05 | 161 | 106 | 5 | 59ae8a7c9a04ecaa335b8064852a5a91a21780bd | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.17e-05 | 161 | 106 | 5 | 08920a716f6ec62538e361211455a30ad726d7be | |
| ToppCell | 390C-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.30e-05 | 162 | 106 | 5 | 45be019b50e3727fc9d3fad2ff78e74e4f2d746b | |
| ToppCell | 390C-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.30e-05 | 162 | 106 | 5 | fbb0cc2b1434a340dc35058b77c73ea61004c252 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.56e-05 | 164 | 106 | 5 | b895674ed2df87db8fbfb30b7e31620945588491 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.97e-05 | 167 | 106 | 5 | 784776d1fcc098f84d3c2eca58fa56cb9428f434 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l44-58|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.97e-05 | 167 | 106 | 5 | d78356bf0c473816dbabaee51984940bd822f84e | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-8|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 5.11e-05 | 168 | 106 | 5 | 00646601548b0fee42ae16bfa5e93603bc7c5129 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.41e-05 | 170 | 106 | 5 | d7c9a604311974ff87ece43a0f8725a234d262f7 | |
| ToppCell | LA-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 5.83e-05 | 88 | 106 | 4 | 7232b13a9788f89600411222c0d93bdc3788816f | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.90e-05 | 179 | 106 | 5 | 4f6ca313b78aa93557937a046c44dcf8bcc9963c | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.86e-05 | 184 | 106 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.86e-05 | 184 | 106 | 5 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 7.86e-05 | 184 | 106 | 5 | d2bf0135eb56bb410997dccea39c5ede88a0617f | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.86e-05 | 184 | 106 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.86e-05 | 184 | 106 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D175|Adult / Lineage, Cell type, age group and donor | 8.06e-05 | 185 | 106 | 5 | 32b4e68e551d435a732f253f6ad83408c759a642 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.06e-05 | 185 | 106 | 5 | 3b2dfc8f4c87be516265dbecfc251276034d0efd | |
| ToppCell | IPF-Lymphoid-B_Plasma|Lymphoid / Disease state, Lineage and Cell class | 8.27e-05 | 186 | 106 | 5 | f9c21daf905d0bb0e0e769ca4bb069ea4b1ba25b | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1|World / Lineage, Cell type, age group and donor | 8.27e-05 | 186 | 106 | 5 | 09d95daa3387a4814cffaa4b798cc2810c3759d0 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Hematopoietic-Myeloid|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.27e-05 | 186 | 106 | 5 | c0a58e43a813441d3a1708236737b15db8bea10e | |
| ToppCell | COVID-19-kidney-DCT|kidney / Disease (COVID-19 only), tissue and cell type | 8.70e-05 | 188 | 106 | 5 | df1fd0819d301679f3c9ea404e942e39095912eb | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.14e-05 | 190 | 106 | 5 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.37e-05 | 191 | 106 | 5 | 44a9a6768084dafc641ad455b65862bfd4cc0cb9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.37e-05 | 191 | 106 | 5 | 39092a0aff8097617820c59f5fea9ee2bb4f63a2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.37e-05 | 191 | 106 | 5 | ee5f1b1c59029c46cbb1a00935c03b9317bb9da9 | |
| ToppCell | Epithelial-club_cell|World / Lineage, Cell type, age group and donor | 9.84e-05 | 193 | 106 | 5 | 2bdd09004fa433550958ec42ba4b06271a4aaf7c | |
| ToppCell | Control-Endothelial-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.84e-05 | 193 | 106 | 5 | aff0649c73c634bc6ff0dc7759b4693a9236bf05 | |
| ToppCell | Control-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.84e-05 | 193 | 106 | 5 | c5f9fe03e64c211d4bcd4959e5b32f14841e336a | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.03e-04 | 195 | 106 | 5 | 4bdedd924564a260841a9153604026b57487c83d | |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.06e-04 | 196 | 106 | 5 | 54f4cf778f95a9ff662e5c7520916a25e605bf95 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-04 | 196 | 106 | 5 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-04 | 196 | 106 | 5 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | PBMC-Control-cDC_3|Control / Compartment, Disease Groups and Clusters | 1.06e-04 | 196 | 106 | 5 | 09d197b321ff9f13c0672ea059c850845b0dbbd5 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.08e-04 | 197 | 106 | 5 | 759f26753f76af3ae8d8527c4d221206245a3d45 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-04 | 197 | 106 | 5 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-04 | 197 | 106 | 5 | e8e3ba791dfaa0fab35e0329a5e34376f9ee6143 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.08e-04 | 197 | 106 | 5 | 5afddde4e2b5cd55abe11e9b9efae02dbdc3da3a | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma-adipo-CAR|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.08e-04 | 197 | 106 | 5 | 1baffd087ca194a7355fefbb3bf67befb14fe2de | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.08e-04 | 197 | 106 | 5 | b9745e382baa2725dfcae060701fb53f6c8a31fa | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Myeloid|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.11e-04 | 198 | 106 | 5 | 79c8ab15e73f727c5e110ab9eab3ccb5edf9f714 | |
| ToppCell | stromal_cell|World / Lineage and Cell class | 1.14e-04 | 199 | 106 | 5 | 507a82d0529b5b1fa5aebcfe43db53f0b6e3f8f0 | |
| ToppCell | stromal_cell-stromal_cell|World / Lineage and Cell class | 1.14e-04 | 199 | 106 | 5 | 74262363a34da3a1eb55ab375fd61ddd7bb39b23 | |
| ToppCell | COPD-Myeloid-Macrophage|Myeloid / Disease state, Lineage and Cell class | 1.14e-04 | 199 | 106 | 5 | 1cf1b2d6debf9e3389f1829dcaa2857e9533a080 | |
| ToppCell | (03)_KRT6B+|World / shred by cell type by condition | 1.14e-04 | 199 | 106 | 5 | 9feaf8649b3f68f30b8cb6b045a2caa2dd343c7f | |
| ToppCell | distal-Hematologic-Classical_Monocyte-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.14e-04 | 199 | 106 | 5 | bd8519da7a90f0b90626b86c6be0d62248a0a24a | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 1.16e-04 | 200 | 106 | 5 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.16e-04 | 200 | 106 | 5 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| Computational | Neighborhood of MAP4K4 | 7.58e-05 | 172 | 65 | 7 | GCM_MAP4K4 | |
| Disease | Syndactyly | 3.20e-04 | 8 | 101 | 2 | C0039075 | |
| Disease | Graves' disease (is_implicated_in) | 3.25e-04 | 39 | 101 | 3 | DOID:12361 (is_implicated_in) | |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 8.08e-04 | 121 | 101 | 4 | EFO_0008595, EFO_0020943 | |
| Disease | alcohol and nicotine codependence | 8.83e-04 | 13 | 101 | 2 | EFO_0004776 | |
| Disease | triglycerides:total lipids ratio, intermediate density lipoprotein measurement | 9.68e-04 | 127 | 101 | 4 | EFO_0008595, EFO_0020947 | |
| Disease | serum albumin measurement | 9.88e-04 | 592 | 101 | 8 | EFO_0004535 | |
| Disease | revision of total hip arthroplasty | 1.03e-03 | 14 | 101 | 2 | EFO_0020973 | |
| Disease | receptive language perception, parental genotype effect measurement | 1.03e-03 | 14 | 101 | 2 | EFO_0005686, EFO_0005939 | |
| Disease | Malignant neoplasm of breast | ABL1 AVPR2 SORBS1 PABPC1 SORCS1 EGF PIM1 ANKRD30A MACF1 FLACC1 AGAP2 | 1.13e-03 | 1074 | 101 | 11 | C0006142 |
| Disease | Dermatitis | 1.35e-03 | 16 | 101 | 2 | C0011603 | |
| Disease | Bronchiectasis | 2.56e-03 | 22 | 101 | 2 | C0006267 | |
| Disease | pulmonary arterial hypertension | 2.56e-03 | 22 | 101 | 2 | EFO_0001361 | |
| Disease | Morbilliform Drug Reaction | 2.80e-03 | 23 | 101 | 2 | C0406537 | |
| Disease | Drug Eruptions | 2.80e-03 | 23 | 101 | 2 | C0011609 | |
| Disease | Behcet Syndrome | 3.05e-03 | 24 | 101 | 2 | C0004943 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RLDSFKDWPRESAVG | 281 | Q13075 | |
| NSSDPENWDRKLHSR | 11 | Q9BSF8 | |
| IWSGNQTLETRDRKP | 351 | O71037 | |
| IWSGNQTLETRDRKP | 351 | Q902F8 | |
| WSGNQTLETRDRKPF | 351 | Q9UKH3 | |
| DGDQWTLSRKRLSCP | 656 | P0C0L5 | |
| SSRGVRPVSFSDWEK | 446 | P22570 | |
| ETSEKFTWAAKGRPR | 401 | Q9BXX3 | |
| ATWRKNRDKDGFSNP | 16 | A6NC57 | |
| WESDTRGRAKPSRDS | 1011 | Q99490 | |
| GTWIRESANKSDDRI | 321 | Q6ZMI3 | |
| RAEAKGNRSWSEESL | 1261 | Q6W2J9 | |
| TSSRRKRDLDGSEDW | 76 | P58397 | |
| RDRTFLEGDWTSPSK | 541 | Q8NDT2 | |
| LEGDWTSPSKSSDRR | 546 | Q8NDT2 | |
| GSKDSDLATQNRPLW | 311 | Q29RF7 | |
| WDTAGQERFKSLRTP | 61 | Q9NP90 | |
| WSQRDPSLRKSGVGN | 86 | P11940 | |
| STLPDWRNAAADNRS | 191 | Q8TAE7 | |
| SGALRRDPSKSTDWE | 31 | Q9H2M9 | |
| WSQRDPSLRKSGVGN | 86 | Q13310 | |
| PSWASARDRQPSDFK | 266 | Q8IYF1 | |
| RAEPRNWTADKEGLR | 531 | A5PL33 | |
| WARDSRDAEPRKKQA | 291 | Q96MG2 | |
| WESEIPDKGRFSRTN | 111 | Q96Q35 | |
| NKLLRTSAPGDWESG | 766 | Q86WG5 | |
| RSQEEPGKGSFWRID | 321 | Q01167 | |
| ARSRELNKPWAAQDG | 196 | Q8N386 | |
| QAWQKRRSSDDAGPG | 1186 | Q8ND23 | |
| ETNADWDGRPTKRSS | 451 | Q5CZC0 | |
| WKINAERSRGEGPEA | 191 | Q9H425 | |
| PKSWSFGDRSRARQA | 481 | O43526 | |
| ADPIITRWKRDSSGN | 171 | Q9BW91 | |
| SEGSRRAADAKPKRW | 911 | Q9H792 | |
| ARRRSLDKWQDEGSS | 436 | Q9UBC0 | |
| GGSSRKELDWLSNPS | 16 | Q9H7Z3 | |
| PWRAREGLDKLVSDA | 1761 | O94854 | |
| EDSRGATLNPWRKAQ | 941 | Q86UT6 | |
| DRNLSDKWSLFGPRS | 216 | Q96A73 | |
| ETRPAGDRTFQKWAA | 256 | P01889 | |
| WSQRDPSLRKSGVGN | 86 | Q9H361 | |
| PRWTRDASISKGDFQ | 296 | Q8IWW6 | |
| SSTDADLPWNRAKNR | 2051 | Q9UMZ3 | |
| KRGNRKSSTSDWPTD | 441 | Q92794 | |
| SAEAWLAEEPKRRGT | 1406 | Q14674 | |
| EAWRREASKSVPSAI | 2236 | Q9Y2F5 | |
| SSLSRKDSRWGDRDS | 881 | Q14152 | |
| WSGNQTLETRDRKPF | 241 | P61566 | |
| IWSGNQTLETRDRKP | 351 | P61570 | |
| IWSGNQTLETRDRKP | 351 | Q69384 | |
| WTDRGKSLIGRSDLN | 571 | P01133 | |
| SDDVLPWRRTAENKL | 61 | P32321 | |
| VRSSDDRLSVAWKAP | 166 | Q4ZHG4 | |
| ERDGKWSTSVFQRTP | 341 | Q4ZHG4 | |
| ARWNSKENLLAGPSE | 46 | P00519 | |
| DRDRATGGWSSSKKR | 156 | Q8TBE0 | |
| AKWRKTERGASDQEP | 86 | A6NNA5 | |
| WSGNQTLETRDRKPF | 351 | P61565 | |
| SLKDEDNARPRSCLW | 256 | Q6PJQ5 | |
| AQSSKREWKPLEDRS | 11 | Q8WWI5 | |
| IWSGNQTLETRDRKP | 351 | Q902F9 | |
| ERDWVLNEFRSGKAP | 456 | Q92841 | |
| LARWEEKTGQRPSEA | 11 | Q4LDG9 | |
| GPDRWNSAFTRKDEI | 16 | Q9UHL9 | |
| EDNLGPQLSKADRWR | 181 | Q9H0W5 | |
| LNSGKAREWTPRDIE | 336 | Q6NYC8 | |
| FPESRKRREAESWNS | 131 | P51170 | |
| DGDQWTLSRKRLSCP | 656 | P0C0L4 | |
| TGRRQKFSPWDDALL | 21 | A6NM36 | |
| GTSKWRRERPESCDD | 496 | Q8NEY1 | |
| KDRISDWGELPNGTR | 71 | P11309 | |
| RDKTNTWSGPREDPN | 266 | Q5JY77 | |
| ENENGALKSRRPSSW | 796 | Q9BVN2 | |
| PRSERKNDNGTEAWG | 466 | Q9HCJ0 | |
| SPSEDNWLKGTRRLD | 141 | Q6P5X7 | |
| WSDRDDATQGRKLSP | 896 | Q9UMZ2 | |
| KPFDPSSWQRERASD | 506 | Q5K651 | |
| TGNWRVRSSPDKDQI | 136 | Q8NA58 | |
| EPGSKWRRNPSDVSD | 1026 | Q8IVL1 | |
| WQAGEDKRSSRLSEP | 611 | Q8TF72 | |
| KRRGASDLSSEEGWR | 141 | P21673 | |
| RRPEAAKEEAAWASS | 81 | O75683 | |
| QAVLPSWDKTERARD | 791 | Q9BVR0 | |
| LQGDSPTKWRTEDFR | 481 | O15042 | |
| DLRPGDVSSKRNLWE | 766 | Q05682 | |
| RAEFSAGAWSEPRKR | 56 | Q8N6S5 | |
| ASEAFPGAWENRTRK | 616 | Q0VD83 | |
| ALGWSREDRPRQNSK | 66 | Q9C0C6 | |
| EERARGAPKQAWNSS | 151 | Q96LP6 | |
| KTGRGPLSDDWARTA | 166 | O00562 | |
| DSSPWSAGKRNRKGE | 96 | Q14186 | |
| ARLEQKQSRAWGPTS | 61 | Q9BZV1 | |
| WPSGARSEQRSAFSK | 151 | Q96MN9 | |
| SRRWSDQLSLDEKDG | 3331 | Q8IZQ1 | |
| SVDKSFSRGWSRDQP | 711 | Q6GYQ0 | |
| NARTRESAWTKPDGV | 151 | O14776 | |
| SSARKNRWDETPKTE | 286 | O75533 | |
| SSWEGTPAESREKNR | 766 | Q9NXL6 | |
| RAKFDRPEATSALWQ | 41 | Q86SX3 | |
| FSSQSKRQPWREESG | 1111 | Q9BX66 | |
| PLGTNSWERDKTCRE | 71 | A7MD48 | |
| PERSGLSWSNREKAK | 266 | Q6NWY9 | |
| QLRSKRDEFWDTAPA | 46 | Q9HAC8 | |
| KGSQRSWPETADRIF | 356 | Q401N2 | |
| NWKDSRGTRVAVSSP | 1321 | Q9ULD9 | |
| KDGWASPQESSLLRS | 1056 | Q9ULL1 | |
| AWRKEQSRPDALITD | 291 | Q9C0D7 | |
| KDRGEWDSLTPEARR | 816 | Q14139 | |
| SPRGTKRRASWASEN | 1856 | Q12789 | |
| KRRASWASENGETDA | 1861 | Q12789 | |
| NKGRDWRLLQAPDTD | 496 | Q8WY21 | |
| SELRRWRSEGADPAK | 141 | P15822 | |
| QDRRWTNPDGTTSKI | 1351 | Q63HR2 | |
| QLAWKATDRFRGPDA | 96 | P30518 | |
| AEWDDLKQLRSSRGG | 1821 | O75096 | |
| AQETWEDKRRGLTLP | 71 | Q96L15 | |
| DEASWRRHQQSPGSK | 351 | Q96P71 |